Interfering with growth inhibition by exogenous TGFβ1 enhances mitotic activity, eventually resulting in a hyper-proliferative state that may have a role in early tumor development prior to mutational inactivation of Smad signaling. This evidence concerns the gene TGFB1 and neoplasm.